NCT07163702View on ClinicalTrials.gov

Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Acute Ischemic Stroke
Interventions
DRUG

High-dose Xinglou Chengqi granules

Patients will receive orally high-dose Xinglou Chengqi granules, combined with guidelines-based standard care.

DRUG

Low-dose Xinglou Chengqi granules and placebo

Patients will receive orally low-dose Xinglou Chengqi granules, combined with guidelines-based standard care.

Trial Locations (1)

V7E 6J1

Dongzhimen Hospital, Beijing University of Chinese Medicine, Richmond

All Listed Sponsors
lead

Dongzhimen Hospital, Beijing

OTHER